KERRILY MURPHY: Open Payments
NPI 1700317377 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$912 in 53 payments from 17 companies in 2025. Trend: 2023 $1,203 · 2024 $1,424 · 2025 $912
Food & beverage: $912
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $262 |
| PFIZER INC. | 8 | $145 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $60 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| Lilly USA, LLC | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Dexcom, Inc. | 1 | $26 |
Products named: NURTEC ODT, QULIPTA, VRAYLAR, UBRELVY, Auvelity, CAPLYTA, TRELEGY ELLIPTA, Kerendia.
Industry payments across AL — which companies pay providers there.
